Monograph Capital Partners — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
HI-Biohibio.comNov 2022acquired by Biogen
Biotech company developing antibodies to treat autoimmune and inflammatory diseases.
Co-investorsArkin CapitalJeito CapitalAlpha Wave GlobalARCH Venture PartnersViking Global Investors
RegASKregask.comin𝕏Dec 2022 · $10M
RegASK provides an AI-native regulatory intelligence platform that monitors regulatory changes across 160+ markets, orchestrates compliance workflows, and pairs automation with a community of regulatory experts for validation.
AI & Machine LearningEnterprise SoftwareSaaS
Caroline Shleifer(Founder)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.